Comment on

• Criteria for the validation of surrogate endpoints in randomized experiments.

  Buyse M, Molenberghs G. Buyse M, et al. Biometrics. 1998 Sep;54(3):1014-29. Biometrics. 1998. PMID: 9840970
• The validation of surrogate endpoints in meta-analyses of randomized experiments.

  Buyse M, Molenberghs G, Burzykowski T, Renard D, Geys H. Buyse M, et al. Biostatistics. 2000 Mar;1(1):49-67. doi: 10.1093/biostatistics/1.1.49. Biostatistics. 2000. PMID: 12933525
• Evolution of Randomized Trials in Advanced/Metastatic Soft Tissue Sarcoma: End Point Selection, Surrogacy, and Quality of Reporting.

  Zer A, Prince RM, Amir E, Abdul Razak A. Zer A, et al. J Clin Oncol. 2016 May 1;34(13):1469-75. doi: 10.1200/JCO.2015.64.3437. Epub 2016 Mar 7. J Clin Oncol. 2016. PMID: 26951308